NovaDel Pharma Inc. Common Stock Purchase Warrant (Void after [_________], 2013)Novadel Pharma Inc • June 3rd, 2008 • Pharmaceutical preparations • New York
NovaDel Pharma Inc., a Delaware corporation (the “Company”), for value received, hereby certifies that [_________], or its registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the six month anniversary after the date of issuance and on or before 5:00 p.m. (Eastern time) on [___________], 2013 (the “Exercise Period”), up to [________] shares of Common Stock, $0.001 par value per share, of the Company (“Common Stock”), at a purchase price of $[ ] per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 3rd, 2008 • Novadel Pharma Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”), dated as of May 6, 2008, is made among NovaDel Pharma Inc., a Delaware corporation (the “Company”), ProQuest Investments II, L.P., ProQuest Investments II Advisors Fund, L.P. and ProQuest Investments III, L.P. (each a “Purchaser” and collectively, the “Purchasers”).
SECURITY AND PLEDGE AGREEMENTSecurity and Pledge Agreement • June 3rd, 2008 • Novadel Pharma Inc • Pharmaceutical preparations • New York
SECURITY AND PLEDGE AGREEMENT entered into as of May 6, 2008 (as from time to time amended, modified, restated, supplemented and in effect, this “Security Agreement”), by NovaDel Pharma Inc., a Delaware corporation (“Grantor”), in favor of ProQuest Investments II, L.P., ProQuest Investments II Advisors Fund, L.P. and ProQuest Investments III, L.P. (collectively, the “Secured Parties”) and ProQuest Investments III, L.P. as collateral agent on behalf of the Secured Parties (the “Collateral Agent”).
AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 3rd, 2008 • Novadel Pharma Inc • Pharmaceutical preparations • New York
This AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT (this “Amendment”), dated as of May 28, 2008, by and among NovaDel Pharma Inc., a Delaware corporation (the “Company”), and those accredited investors listed on the signature pages attached hereto (the “Purchasers”).
